Around 27% of healthcare workers in Kashmir developed antibodies against COVID-19, finds sero-survey

The sero-survey was based on samples from 2,013 healthcare workers. The samples were collected from hospitals affiliated with Srinagar's GMC hospital, and also from district and police hospitals

Press Trust of India February 07, 2021 17:57:42 IST
Around 27% of healthcare workers in Kashmir developed antibodies against COVID-19, finds sero-survey

Representational image. PTI

Srinagar: A sero survey conducted in various hospitals of the Kashmir Valley has found that around 27 percent of the healthcare workers have antibodies against COVID-19 .

"A sero prevalence study was conducted by Government Medical College (GMC), Srinagar among healthcare providers of the Kashmir Division in January to detect SARS-CoV-2 specific IgG antibodies," said Muhammad Salim Khan, head of community medicine at GMC.

He said a total of 2,013 samples were collected from all GMC, Srinagar-affiliated hospitals, district hospitals and police hospitals in Srinagar by the Department of Community Medicine.

"The blood samples were tested in Abbott Architect i1000SR immunoassay analyser by the Department of Biochemistry and 555 blood samples showed IgG antibodies with an overall sero positivity of 27.3 percent," Khan said.

He said the study shows that healthcare providers should definitely go for COVID-19 vaccination as the majority among them were still susceptible to the infection.

"There is some reluctance among healthcare providers, but no severe or serious adverse events following immunization (AEFI) has been reported among thousands of healthcare workers who received the vaccines in Jammu and Kashmir in the last few weeks," Khan said.

He said while the Centre has asked to go for mopping up round with the second dose of COVID-19 vaccine from 13 February, it is imperative that all healthcare workers shall receive the first jab before that.

"The vaccine not only protects the recipient but shall facilitate to achieve the herd immunity against COVID-19 ," Khan said.

Updated Date:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

COVID-19 variants: EU to launch incubator for 'second gen' vaccines against future strains
World

COVID-19 variants: EU to launch incubator for 'second gen' vaccines against future strains

The 'HERA incubator' will bring together the pharmaceutical industry, laboratories, health authorities and researchers, a spokesperson said.

First dose of Pfizer, AstraZeneca shots cut transmission, hospitalisation risk, say UK studies
World

First dose of Pfizer, AstraZeneca shots cut transmission, hospitalisation risk, say UK studies

Being the first nation to begin mass vaccinations in December, over 17 million UK resident have received at least a first dose so far.

Tokyo Olympics 2020: Japan begins COVID-19 vaccination drive amid Summer Games worries
Sports

Tokyo Olympics 2020: Japan begins COVID-19 vaccination drive amid Summer Games worries

The fate of the Tokyo Olympics and the billions of dollars at stake should the Games fail, makes Japan's vaccine campaign crucial.